The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy

Alzheimer disease (AD) is characterized by the deposition of amyloid fibrils, such as senile plaques, composed of amyloid β peptide (Aβ). As a novel therapeutic modality, we have previously developed an azobenzene-boron complex type photocatalyst that photo-oxygenates Aβ fibrils. And the in vivo photo-oxygenation reaction using this photocatalyst successfully reduced the Aβ fibrils in the brain. Since Aβ fibril is one of the causative molecules in the brains of AD patients, the photocatalyst is expected to be a new modality for disease-modifying therapy against AD. However, the exact relationship between light energy and photo-oxygenating activity for Aβ fibrils remains unclear. In this paper, we have demonstrated using mass spectrometric analysis that the number of oxygens added to Aβ fibrils was increased in a sigmoidal curve with the logarithm of light energy. We also showed that it depended on the total light energy, not on the irradiance. These data suggest that photo-oxygenation proceeds at even lower levels of light energy, and it may be possible to induce photo-oxygenation in areas where light penetration is difficult, such as the human brain.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-07-12
DOI
https://doi.org/10.1038/s41598-025-10880-8
Citations
1
Primary Topic
Supramolecular Self-Assembly in Materials
Type
article
Field-Weighted Citation Impact
0.60

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy

Yuichi Kawai, Youhei Sohma, Motomu Kanai, Yukiko Hori et al.
1 citations
Scientific Reports
Supramolecular Self-Assembly in Materials
0.60
article

The dynamics of oxygenation to Aβ fibrils using an azobenzene–boron complex type photocatalyst and light energy

Yuichi Kawai, Youhei Sohma, Motomu Kanai, Yukiko Hori, Taisuke Tomita, Mai Kuriyama
article en
1 citations

Abstract

Alzheimer disease (AD) is characterized by the deposition of amyloid fibrils, such as senile plaques, composed of amyloid β peptide (Aβ). As a novel therapeutic modality, we have previously developed an azobenzene-boron complex type photocatalyst that photo-oxygenates Aβ fibrils. And the in vivo photo-oxygenation reaction using this photocatalyst successfully reduced the Aβ fibrils in the brain. Since Aβ fibril is one of the causative molecules in the brains of AD patients, the photocatalyst is expected to be a new modality for disease-modifying therapy against AD. However, the exact relationship between light energy and photo-oxygenating activity for Aβ fibrils remains unclear. In this paper, we have demonstrated using mass spectrometric analysis that the number of oxygens added to Aβ fibrils was increased in a sigmoidal curve with the logarithm of light energy. We also showed that it depended on the total light energy, not on the irradiance. These data suggest that photo-oxygenation proceeds at even lower levels of light energy, and it may be possible to induce photo-oxygenation in areas where light penetration is difficult, such as the human brain.

Scientific ReportsVol. 15(1)
Wakayama Medical University (JP), IHI Corporation (Japan) (JP), The University of Tokyo (JP)
Japan Agency for Medical Research and Development, Ushio, University of Tokyo, Japan Society for the Promotion of Science
Affordable and clean energy
Openalex Percentile: Top 32%
Supramolecular Self-Assembly in Materials
0.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.